Perindopril erbumine is the tert-butylamine salt of a third generation long-acting angiotensin-converting enzyme (ACE) inhibitor, perindopril, the free acid form of perindopril erbumine.
Two years ago, Novartis launched a big trials programme for its heart failure drug Entresto in the hope of revving up disappointing initial sales, and one of those trials has just delivered positive results.